+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cost benefit analysis of the treatment of tuberculosis in Poland in the years 1966-1975

Cost benefit analysis of the treatment of tuberculosis in Poland in the years 1966-1975

Pneumonologia Polska 46(11): 765-772

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 038926158

Download citation: RISBibTeXText

PMID: 101974

Related references

Cost and benefit prognosis from tuberculosis treatment programs in Poland in the years 1975-2000. Pneumonologia Polska 47(1): 3-10, 1979

Registered morbidity from active, sputum-positive pulmonary tuberculosis in the former Konin district in the years 1966-1975. Pneumonologia Polska 44(11-12): 1041-1047, 1976

A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program. Bmc Public Health 15: 1201, 2015

Analysis of vision loss following injuries in the years 1966--1975. Klinika Oczna 81(5-6): 375-377, 1979

Clinical analysis of bronchopneumonia in infants in the years 1966-1975. Pediatria Polska 53(10): 1203-1210, 1978

Drug resistance in patients with tuberculosis in Poland in the years 1966-1992. A test for evaluating the scale of the problem. Pneumonologia i Alergologia Polska 63(1-2): 14-20, 1995

Luxatio patellae congenita of dog-treatment and results in the years 1966-1975. 1977

A cost benefit analysis of Manitoba's integrated Dutch elm disease management program 1975-1990. Proceedings of the Entomological Society of Manitoba ( 47): 44-59, 1991

Cost benefit analysis of HPN programme in first year of health care reform in Poland. Clinical Nutrition 19(Suppl. 1): 55, 2000

Taeniasis in Poland in 1966-1975. Polski Tygodnik Lekarski 32(36): 1397-1399, 1977

Nutrition habits of men in Poland in the years 1975-1984. A review and analysis of studies. Roczniki Panstwowego Zakadu Higieny 42(1): 41-50, 1991

A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value in Health 16(1): 66-75, 2013

A cost-benefit analysis of scaling up tuberculosis control in India. International Journal of Tuberculosis and Lung Disease 15(3): 358-362, 2011

Epidemiologic analysis of pertussis in Poland on the basis of representative studies in selected territories in the years 1966-67. Przeglad Epidemiologiczny 23(3): 387-393, 1969

Cost-benefit and cost-effectiveness analysis of drug abuse treatment services. Evaluation Review 22(5): 609-636, 1998